KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, Inc. announced today it has closed $35.5 million in new venture capital. This Series D financing was co-led by Johnson & Johnson Development Corp. (JJDC) and Lumira Capital, and included Mitsubishi UFJ Capital, West River Capital, and Montgomery & Co. Also participating were existing investors Frazier Healthcare Ventures, Interwest Partners, MPM Capital, and Polaris Venture Partners. Funds will be used to execute clinical trials in the U.S. and Europe supporting the CARILLON™ Mitral Contour System™. Montgomery & Co., LLC served as the exclusive private placement agent on this financing. The CARILLON™ system is a percutaneous treatment of functional mitral regurgitation (FMR), and is currently under evaluation in pilot studies in Europe, South America, and Australia.
